Autoimmune Hepatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working
DelveInsight’s “Autoimmune Hepatitis – Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Autoimmune Hepatitis, historical and forecasted epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Autoimmune Hepatitis Market Report:
Autoimmune hepatitis develops when the body's immune system, which normally targets viruses, bacteria, and other pathogens, instead targets the liver
New cases (incidence) are expected to be 1-2 per 100,000 each year, with overall cases (prevalence) being around 24 per 100,000. According to studies, the incidence of AIH is on the rise, and the cause is unknown
Women are more likely than men to develop the condition, and women are usually diagnosed in their 40s or 50s
Researchers believe that autoimmune hepatitis is caused by the combination of genes that affect immune system activity
Got queries? Click here to know more about the Autoimmune Hepatitis Market Landscape.
Autoimmune Hepatitis Overview:
Autoimmune Hepatitis is the condition where the liver gets inflamed and it usually occurs when the body’s immune system turns against the liver cells. The real cause is unknown for Autoimmune Hepatitis, but the genetic and some environmental factors are focused over time to trigger the disease.
If left untreated, autoimmune hepatitis can cause liver scarring (cirrhosis) and finally liver failure. However, autoimmune hepatitis can typically be controlled with immune-suppressing medicines if recognized and treated early.
This disease does not affect the major population, 1-2 out of 100000/year are affected by this disease. And women are more prone to get affected by Autoimmune Hepatitis than men.
Autoimmune Hepatitis Symptoms:
The symptoms of Autoimmune Hepatitis can differ from a person to person and can show up suddenly. The few symptoms that can be seen in the person affected with Autoimmune Hepatitis are-
Body Fatigue
Rashes on skin
An Enlarged Liver
Abnormal Blood vessels on the skin
Yellowing of the Skin with the Whites of the Eyes (Jaundice)
Pain in Joints
Changes in Menstrual Cycle
Autoimmune Hepatitis Market
The dynamics of the Autoimmune Hepatitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as and others during the forecasted period 2018-2030.
The key companies leading the research in the field of Autoimmune Hepatitis are the - Dr. Falk Pharma GmbH, Novartis Pharmaceuticals, University of Sao Paulo General Hospital, TaiwanJ Pharmaceuticals Co., Ltd, Tehran University of Medical Sciences, Xiaoli Fan.
Learn more by requesting for sample @ Autoimmune Hepatitis Market Landscape
Autoimmune Hepatitis Pipeline Therapies:
Chloroquine diphosphate
Budesonide
sPIF
JKB-122
Cyclosporine-A
Methylprednisolone and Mycophenolate mofetil
Autoimmune Hepatitis Key Companies:
Dr. Falk Pharma GmbH
Novartis Pharmaceuticals
University of Sao Paulo General Hospital
TaiwanJ Pharmaceuticals Co., Ltd
Tehran University of Medical Sciences
Xiaoli Fan
Related Reports:
Autoimmune Hepatitis Pipeline
"Autoimmune Hepatitis Pipeline Insight, 2021" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Autoimmune Hepatitis market. A detailed picture of the Autoimmune Hepatitis pipeline landscape is provided, which includes the disease overview and Autoimmune Hepatitis treatment guidelines.
Autoimmune Hepatitis Epidemiology
DelveInsight's 'Autoimmune Hepatitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Autoimmune Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Comments
Post a Comment